Mathew B - Search Results

1

Urachal carcinoma: The journey so far and the road ahead.

Kumar R, Harilal S, Abdelgawad MA, Ghoneim MM, Kumar A, Mathew B. Kumar R, et al. Among authors: mathew b. Pathol Res Pract. 2023 Mar;243:154379. doi: 10.1016/j.prp.2023.154379. Epub 2023 Feb 17. Pathol Res Pract. 2023. PMID: 36821941 Review.

2

KIF1A-Associated Neurological Disorder: An Overview of a Rare Mutational Disease.

Nair A, Greeny A, Rajendran R, Abdelgawad MA, Ghoneim MM, Raghavan RP, Sudevan ST, Mathew B, Kim H. Nair A, et al. Among authors: mathew b. Pharmaceuticals (Basel). 2023 Jan 19;16(2):147. doi: 10.3390/ph16020147. Pharmaceuticals (Basel). 2023. PMID: 37259299 Free PMC article. Review.

3

MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.

Sasidharan R, Mohanan R, Kukreti N, Raj P, Abdelgawad MA, Ghoneim MM, Manju SL, Mathew B. Sasidharan R, et al. Among authors: mathew b. Neurochem Res. 2024 Jun;49(6):1518-1528. doi: 10.1007/s11064-023-04031-6. Epub 2023 Oct 9. Neurochem Res. 2024. PMID: 37814132

4

Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence.

Devan AR, Nair B, Aryan MK, Liju VB, Koshy JJ, Mathew B, Valsan A, Kim H, Nath LR. Devan AR, et al. Among authors: mathew b. Cancers (Basel). 2023 May 12;15(10):2729. doi: 10.3390/cancers15102729. Cancers (Basel). 2023. PMID: 37345066 Free PMC article. Review.

5

Mycobacterial FtsZ and inhibitors: a promising target for the anti-tubercular drug development.

Shinde Y, Pathan A, Chinnam S, Rathod G, Patil B, Dhangar M, Mathew B, Kim H, Mundada A, Kukreti N, Ahmad I, Patel H. Shinde Y, et al. Among authors: mathew b. Mol Divers. 2023 Nov 27. doi: 10.1007/s11030-023-10759-8. Online ahead of print. Mol Divers. 2023. PMID: 38010605 Review.

6

Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders.

Srivastava P, Sudevan ST, Thennavan A, Mathew B, Kanthlal SK. Srivastava P, et al. Among authors: mathew b. CNS Neurol Disord Drug Targets. 2024;23(3):331-341. doi: 10.2174/1871527322666230303115236. CNS Neurol Disord Drug Targets. 2024. PMID: 36872357

7

Flavonoid and Chalcone Scaffolds as Inhibitors of BACE1: Recent Updates.

Narayanan AP, Jayan J, Sudevan ST, Dhyani A, Zachariah SM, Mathew B. Narayanan AP, et al. Among authors: mathew b. Comb Chem High Throughput Screen. 2023 Jul 31. doi: 10.2174/1386207326666230731092409. Online ahead of print. Comb Chem High Throughput Screen. 2023. PMID: 37519205

8

Correction to: Targeting cellular batteries for the therapy of neurological diseases.

Arora A, Behl T, Sehgal A, Singh S, NeelamSharma, Mathew B, Bungau S. Arora A, et al. Among authors: mathew b. Environ Sci Pollut Res Int. 2024 May 6. doi: 10.1007/s11356-024-33596-0. Online ahead of print. Environ Sci Pollut Res Int. 2024. PMID: 38705928 No abstract available.

9

Enzyme Inhibition Assays for Monoamine Oxidase.

Mathew B, Oh JM, Parambi DGT, Sudevan ST, Kumar S, Kim H. Mathew B, et al. Methods Mol Biol. 2024;2761:329-336. doi: 10.1007/978-1-0716-3662-6_24. Methods Mol Biol. 2024. PMID: 38427248

10

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2.

Ryan M, Taylor D, Dodd M, Spertus JA, Kosiborod MN, Shaukat A, Docherty KF, Clayton T, Perera D, Petrie MC; REVIVED-BCIS2 Investigators. Ryan M, et al. JACC Heart Fail. 2024 Apr 8:S2213-1779(24)00264-6. doi: 10.1016/j.jchf.2024.03.010. Online ahead of print. JACC Heart Fail. 2024. PMID: 38727649 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

763 results

Search Page